CA2426405A1 - Estrogen receptor alpha variants and methods of detection thereof - Google Patents

Estrogen receptor alpha variants and methods of detection thereof Download PDF

Info

Publication number
CA2426405A1
CA2426405A1 CA002426405A CA2426405A CA2426405A1 CA 2426405 A1 CA2426405 A1 CA 2426405A1 CA 002426405 A CA002426405 A CA 002426405A CA 2426405 A CA2426405 A CA 2426405A CA 2426405 A1 CA2426405 A1 CA 2426405A1
Authority
CA
Canada
Prior art keywords
nucleic acid
estrogen receptor
protein
sequence
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002426405A
Other languages
English (en)
French (fr)
Inventor
Francis Kalush
Michael J. Cassel
Stuart Soo-In Hwang
Emily S. Winn-Deen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Biosystems Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2426405A1 publication Critical patent/CA2426405A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002426405A 2000-10-20 2001-08-21 Estrogen receptor alpha variants and methods of detection thereof Abandoned CA2426405A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US69241400A 2000-10-20 2000-10-20
US09/692,414 2000-10-20
US76818401A 2001-01-24 2001-01-24
US09/768,184 2001-01-24
US80407601A 2001-03-13 2001-03-13
US09/804,076 2001-03-13
US82631401A 2001-04-05 2001-04-05
US09/826,314 2001-04-05
PCT/US2001/025990 WO2002034945A2 (en) 2000-10-20 2001-08-21 Estrogen receptor alpha variants and methods of detection thereof

Publications (1)

Publication Number Publication Date
CA2426405A1 true CA2426405A1 (en) 2002-05-02

Family

ID=27505440

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002426405A Abandoned CA2426405A1 (en) 2000-10-20 2001-08-21 Estrogen receptor alpha variants and methods of detection thereof

Country Status (5)

Country Link
EP (1) EP1328661A2 (ja)
JP (1) JP2004531228A (ja)
AU (1) AU2001286560A1 (ja)
CA (1) CA2426405A1 (ja)
WO (1) WO2002034945A2 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020123095A1 (en) * 1999-10-20 2002-09-05 Pe Corporation (Ny) Estrogen receptor alpha variants and methods of detection thereof
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
IL254129B2 (en) 2015-03-27 2023-10-01 Immatics Biotechnologies Gmbh New peptides and a combination of peptides for use in immunotherapy against various tumors

Also Published As

Publication number Publication date
JP2004531228A (ja) 2004-10-14
EP1328661A2 (en) 2003-07-23
WO2002034945A3 (en) 2002-08-08
WO2002034945A2 (en) 2002-05-02
AU2001286560A1 (en) 2002-05-06

Similar Documents

Publication Publication Date Title
AU2017267184B2 (en) Method for assessing a prognosis and predicting the response of patients with malignant diseases to immunotherapy
KR102291355B1 (ko) Pd-l1 억제제 공동치료를 필요로 하는 환자의 식별방법
US20230056182A1 (en) Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear
AU2016364667A1 (en) Materials and methods for treatment of Alpha-1 antitrypsin deficiency
CN107223159A (zh) 源自特定细胞类型的dna的检测及相关方法
AU2016351889A1 (en) Detection of foetal chromosomal aneuploidies using DNA regions that are differentially methylated between the foetus and the pregnant female
WO1998045436A2 (en) SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
CA2936612A1 (en) Atf6 polymorphisms associated with myocardial infarction, method of detection and uses thereof
WO1998045437A2 (en) SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
KR20210027384A (ko) Scn9a 발현을 조절하기 위한 올리고뉴클레오티드
KR20220012230A (ko) 스플라이싱 및 번역을 조절하기 위한 방법 및 조성물
KR20160037895A (ko) 성장 호르몬 수용체의 조절인자
KR20220025749A (ko) 대장암의 검출
KR20220024184A (ko) 대장암의 검출
KR20100128298A (ko) 카텝신 c의 용도
WO2006022629A1 (en) Methods of identifying risk of type ii diabetes and treatments thereof
CA2458202A1 (en) Estrogen receptor alpha variants and methods of detection thereof
CN101151371A (zh) 治疗中的逆转录转座子抑制
CN111344408A (zh) 用于调控fndc3b表达的寡核苷酸
CA2400915A1 (en) Estrogen receptor alpha variants and methods of detection thereof
WO2006022636A1 (en) Methods for identifying risk of type ii diabetes and treatments thereof
CA2474759A1 (en) Gene for peripheral arterial occlusive disease
US6818758B2 (en) Estrogen receptor beta variants and methods of detection thereof
CA2426405A1 (en) Estrogen receptor alpha variants and methods of detection thereof
KR20230005933A (ko) Atxn1을 조정하는 화합물 및 방법

Legal Events

Date Code Title Description
FZDE Discontinued